{"id":390552,"date":"2020-12-01T08:08:19","date_gmt":"2020-12-01T13:08:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=390552"},"modified":"2020-12-01T08:08:19","modified_gmt":"2020-12-01T13:08:19","slug":"hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/","title":{"rendered":"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection<\/b><\/p>\n<p class=\"bwalignc\"><i>Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius<sup>\u00ae<\/sup> 3D Mammography<sup>\u2122<\/sup> exam*<sup>1<\/sup><\/i><\/p>\n<p>MARLBOROUGH, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nHologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women\u2019s health, today announced U.S. Food and Drug Administration (FDA) clearance and commercial availability of the Company\u2019s Genius AI<sup>\u2122<\/sup> Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20201201005204\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201201005204\/en\/<\/a><\/p>\n<p>\nThe new technology represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius AI Detection software aids in the identification and early detection of breast cancer when used with the Genius<sup>\u00ae<\/sup> 3D Mammography<sup>\u2122<\/sup> exam.*<sup>1<\/sup> The new technology highlights areas with subtle potential cancers that can be difficult to detect for further examination by the radiologist, and is designed to provide higher sensitivity and a false-positive rate much lower than Hologic\u2019s previous generation CAD products.\n<\/p>\n<p>\n\u201cAs the latest breakthrough in breast cancer screening, Genius AI Detection reinforces Hologic\u2019s commitment to improving cancer detection, optimizing workflow and enhancing the patient experience across every step of the breast health care continuum,\u201d said Jennifer Meade, Hologic\u2019s Division President, Breast and Skeletal Health Solutions. \u201cNot only did studies show that Genius AI Detection aids in image interpretation by highlighting suspicious, and often subtle, areas of interest, it also provides the radiologist the opportunity to prioritize the most concerning patient cases. This is a real game changer as it has the potential to shorten the cycle between screening and diagnostic follow-up, and ultimately improve patient outcomes.\u201d\n<\/p>\n<p>\nThe new software delivers key metrics at the time of image acquisition to help radiologists categorize and prioritize cases by complexity and expected read time in order to optimize workflow and expedite patient care. It is the only deep learning product on the market that runs on the acquisition workstation of the mammography system without the need for a separate server, providing a simple, convenient and secure environment.\n<\/p>\n<p>\nThe Genius AI Detection software is the only 3D CAD solution that supports Hologic\u2019s latest innovations in tomosynthesis imaging, Clarity HD\u2122 and 3DQuorum\u2122 imaging technology, in addition to standard-resolution tomosynthesis. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.hologic.com%2FGeniusAI-Detection&amp;esheet=52339730&amp;newsitemid=20201201005204&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.hologic.com%2FGeniusAI-Detection&amp;index=1&amp;md5=9966fd47b9166d4d9477ca7a393cddcc\">https:\/\/www.hologic.com\/GeniusAI-Detection<\/a>.\n<\/p>\n<p>\nThe Genius<sup>\u00ae<\/sup> 3D Mammography<sup>\u2122<\/sup> exam is acquired on the Hologic<sup>\u00ae<\/sup> 3D Mammography<sup>\u2122<\/sup> system and consists of a 2D and 3D<sup>\u2122<\/sup> image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D<sup>\u2122<\/sup> image set. The Genius exam is only available on the Hologic<sup>\u00ae<\/sup> 3D Mammography<sup>\u2122<\/sup> system.\n<\/p>\n<p><b><span class=\"bwuline\">About Hologic, Inc.<\/span><\/b><\/p>\n<p>\nHologic, Inc. is an innovative medical technology company primarily focused on improving women\u2019s health and well-being through early detection and treatment. For more information on Hologic, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.hologic.com&amp;esheet=52339730&amp;newsitemid=20201201005204&amp;lan=en-US&amp;anchor=www.hologic.com&amp;index=2&amp;md5=dfe977345a13e0bcb5c56f1ad553c9fd\">www.hologic.com<\/a>.\n<\/p>\n<p>\nHologic, 3D, 3D Mammography, 3DQuorum, Genius, Genius AI and Hologic Clarity HD are trademarks and\/or registered trademarks of Hologic, Inc., and\/or its subsidiaries in the United States and\/or other countries.\n<\/p>\n<p><b><span class=\"bwuline\">Forward-Looking Statements<\/span><\/b><\/p>\n<p>\nThis news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic breast cancer detection products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.\n<\/p>\n<p>\nThis information is not intended as a product solicitation or promotion where such activities are prohibited. For specific information on what products are available for sale in a particular country, please contact a local Hologic sales representative or write to <a rel=\"nofollow\" href=\"mailto:womenshealth@hologic.com\">womenshealth@hologic.com<\/a>.\n<\/p>\n<p>\n*Based on analyses that do not control type I error and therefore cannot be generalized to specific comparisons outside this particular study. In this study: The average observed reader sensitivity for cancer cases was 75.9% with CAD and 66.8% without CAD. The difference in observed sensitivity was +9.0% (99% CI: 6.0%, 12.1%).\n<\/p>\n<p>\n1. FDA Clearance: K201019\n<\/p>\n<p>\nSOURCE: Hologic, Inc.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201201005204\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201201005204\/en\/<\/a><\/span><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Jane Mazur<br \/>\n<br \/>508.263.8764 (direct)<br \/>\n<br \/>585.355.5978 (mobile)<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:jane.mazur@hologic.com\">jane.mazur@hologic.com<\/a><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>Michael Watts<br \/>\n<br \/>858.410.8588<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:jane.mazur@hologic.com\">michael.watts@hologic.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Medical Devices FDA Public Relations\/Investor Relations Communications Radiology General Health Health Science Oncology Other Science<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201201005204\/en\/842817\/3\/4304156cHologic_Main_Logo_Small_White_cropped.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius\u00ae 3D Mammography\u2122 exam*1 MARLBOROUGH, Mass.&#8211;(BUSINESS WIRE)&#8211; Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women\u2019s health, today announced U.S. Food and Drug Administration (FDA) clearance and commercial availability of the Company\u2019s Genius AI\u2122 Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201201005204\/en\/ The new technology represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-390552","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius\u00ae 3D Mammography\u2122 exam*1 MARLBOROUGH, Mass.&#8211;(BUSINESS WIRE)&#8211; Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women\u2019s health, today announced U.S. Food and Drug Administration (FDA) clearance and commercial availability of the Company\u2019s Genius AI\u2122 Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201201005204\/en\/ The new technology represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius &hellip; Continue reading &quot;Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-01T13:08:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection\",\"datePublished\":\"2020-12-01T13:08:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/\"},\"wordCount\":836,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/\",\"name\":\"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-12-01T13:08:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/","og_locale":"en_US","og_type":"article","og_title":"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection - Market Newsdesk","og_description":"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius\u00ae 3D Mammography\u2122 exam*1 MARLBOROUGH, Mass.&#8211;(BUSINESS WIRE)&#8211; Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women\u2019s health, today announced U.S. Food and Drug Administration (FDA) clearance and commercial availability of the Company\u2019s Genius AI\u2122 Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201201005204\/en\/ The new technology represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius &hellip; Continue reading \"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-01T13:08:19+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection","datePublished":"2020-12-01T13:08:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/"},"wordCount":836,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/","name":"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-12-01T13:08:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201201005204r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-receives-fda-clearance-for-latest-breakthrough-in-early-breast-cancer-detection-genius-ai-detection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI\u2122 Detection"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=390552"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390552\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=390552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=390552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=390552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}